Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 2
1973 6
1974 5
1975 4
1976 4
1977 6
1978 10
1979 14
1980 20
1981 9
1982 9
1983 5
1984 5
1985 3
1986 11
1987 7
1988 5
1989 9
1990 9
1991 9
1992 7
1993 10
1994 7
1995 11
1996 8
1997 8
1998 9
1999 7
2000 10
2001 10
2002 9
2003 15
2004 22
2005 20
2006 24
2007 25
2008 30
2009 41
2010 44
2011 43
2012 106
2013 190
2014 227
2015 202
2016 191
2017 212
2018 186
2019 186
2020 187
2021 198
2022 121
2023 84
2024 72

Search Results

2,282 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
Makker V, Colombo N, Casado Herráez A, Monk BJ, Mackay H, Santin AD, Miller DS, Moore RG, Baron-Hay S, Ray-Coquard I, Ushijima K, Yonemori K, Kim YM, Guerra Alia EM, Sanli UA, Bird S, Orlowski R, McKenzie J, Okpara C, Barresi G, Lorusso D. Makker V, et al. J Clin Oncol. 2023 Jun 1;41(16):2904-2910. doi: 10.1200/JCO.22.02152. Epub 2023 Apr 14. J Clin Oncol. 2023. PMID: 37058687 Free PMC article. Clinical Trial.
Lenvatinib-Associated Erythrocytosis.
Lakra R, Grewal US, Beedupalli K. Lakra R, et al. Am J Ther. 2024 Mar-Apr 01;31(2):e201-e203. doi: 10.1097/MJT.0000000000001606. Epub 2023 Mar 7. Am J Ther. 2024. PMID: 36989234 No abstract available.
Regorafenib for the Treatment of Sarcoma.
Blay JY, Duffaud F, George S, Maki RG, Penel N. Blay JY, et al. Curr Treat Options Oncol. 2022 Nov;23(11):1477-1502. doi: 10.1007/s11864-022-00990-0. Epub 2022 Sep 30. Curr Treat Options Oncol. 2022. PMID: 36178573 Review.
Quizartinib (Vanflyta) for acute myeloid leukemia.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2023 Oct 16;65(1687):e169-e170. doi: 10.58347/tml.2023.1687d. Med Lett Drugs Ther. 2023. PMID: 37871118 No abstract available.
Sorafenib-induced eccrine squamous syringometaplasia.
Velik C, De Rosa N, Kearney D, Sidhu S. Velik C, et al. Australas J Dermatol. 2022 May;63(2):e189-e190. doi: 10.1111/ajd.13795. Epub 2022 Feb 4. Australas J Dermatol. 2022. PMID: 35119099 No abstract available.
2,282 results